help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, A.
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 314, (2007)
© 2007 American Thoracic Society


Correspondence

Does Regular Physical Activity Reduce Lung Function Decline and COPD Risk among Smokers?

To the Editor:

I read with interest the recent article by Garcia-Aymerich and colleagues wherein the authors have tried to demonstrate that moderate to high levels of regular physical activity are associated with reduced lung function decline and risk of chronic obstructive pulmonary disease (COPD) among smokers (1). This study does not take into consideration the very fact that there is intersubject variability in the inflammatory response in COPD since only 10 to 20% of heavy smokers develop symptomatic airflow obstruction (2). The inappropriate inflammatory response that occurs in cigarette smokers who develop COPD compared with smokers without COPD can be explained by genetic polymorphisms (3). Even among patients with severe COPD, there may be varying levels of disability despite similar levels of lung function. Polymorphisms in several genes appear to be associated with COPD-related traits other than forced expiratory volume in 1 second (3).

Considering the smoking-induced inflammatory nature of COPD pathogenesis, the authors put forward the hypothesis that higher levels of regular physical activity could reduce the risk of COPD by modifying smoking-related lung function decline (1). It is logical to expect that, if COPD is purely an inflammatory condition, corticosteroids should be beneficial, but the response to corticosteroids in COPD has been disappointing (4). Besides inflammation, continued proteolytic activity results in parenchymal destruction and obliterative bronchiolitis and fibrosis.

If strenuous physical activity is protective against the development of COPD, with a 21% reduction in the occurrence of new COPD cases in the present study, then why is COPD rampant in the hills of the Himalayas (5) and in manual workers (6). The present study does not take into consideration the confounding effects of diet and of statins on the rate of decline of lung function (7). Even in this study, the lack of an association between physical activity and lung function decline or COPD risk in the group of former smokers brings into question the authors' hypothesis that the antiinflammatory action of physical activity prevents the onset of COPD in the smokers. Their valuable findings should not be taken as supportive for cigarette abuse, but as overall health promotion through regular moderate to high levels of physical activity.

Akashdeep Singh

Christian Medical College and Hospital Ludhiana, Ludhiana, India

FOOTNOTES

Conflict of Interest Statement: A.S. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript.

REFERENCES

  1. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007;175:458–463.[Abstract/Free Full Text]
  2. Tashkin DP, Detels R, Simmons M, Liu H, Coulson AH, Sayre J, Rokaw S. The UCLA population studies of chronic obstructive respiratory disease: impact of air pollution and smoking on annual change in forced expiratory volume in one second. Am J Respir Crit Care Med 1994;149:1209–1217.[Abstract]
  3. Hersh CP, DeMeo DL, Lazarus R, Celedon JC, Raby BA, Reilly JJ, Silverman EK. Genetic determinants of functional impairment in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:476.[Free Full Text]
  4. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997;155:542–548.[Abstract]
  5. Pandey MR. Prevalence of chronic bronchitis in a rural community of the hill region of Nepal. Thorax 1984;39:331–336.[Abstract/Free Full Text]
  6. Hu Y, Chen B, Yin Z, Jia L, Zhou Y, Jin T. Increased risk of chronic obstructive pulmonary diseases in coke oven workers: interaction between occupational exposure and smoking. Thorax 2006;61:290–295.[Abstract/Free Full Text]
  7. Soyseth V, Brekke PH, Smith P, Omland T. Statin use is associated with reduced mortality in COPD. Eur Respir J 2007;29:279–283.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society